Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06781853 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

CBT for Muscle Dysmorphia and Steroid Abuse: A Randomized Controlled Trial

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study completion date: Jun 2025 to Jun 15, 2025
    • Study description shortened, about 16 words
    v3
  2. Collaborators revised (2)v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to evaluate the effectiveness of cognitive behavioral therapy (CBT) in treating muscle dysmorphia (MD) under body dysmorphic disorder (BDD) and steroid/performance-enhancing drug (PED) abuse in men aged 18-65 who regularly attend the gym. The main questions it aims to answer are: Does CBT reduce the symptoms of muscle dysmorphia in this population? Does CBT improve psychological well-being and reduce reliance on steroids or PEDs? Researchers will compare participants receiving CBT to a control group that does not receive any intervention to determine the therapy's effectiveness. Participants will: Undergo a formal diagnosis of muscle dysmorphia (Under BDD) and steroid/PED abuse based on DSM-5-TR criteria through online clinical interviews. Complete 12 weekly one-on-one online CBT sessions (50 minutes each) for those in the experimental group. Complete psychological assessments at three time points: before the intervention, after the intervention, and at a 3-month follow-up. This study uses validated scales to measure changes in symptoms of MD, psychological distress, and other related outcomes. The results will help determine if CBT is an effective treatment for muscle dysmorphia and associated steroid/PED abuse.
Trial Details
NCT Number NCT06781853
Lead Sponsor Uskudar University
Collaborators: Beykoz University, Istanbul Nisantasi University
Conditions
(from sponsor)		 Body Dysmorphic Disorder, Steroid Abuse, Body Dysmorphic Disorder (BDD), Subtype: Muscle Dysmorphia
Related terms Body Dysmorphic Disorders, Brachydactyly, Type D
Enrollment 71 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov